Background-Hospitals enrolled in the American Heart Association's Get With The Guidelines Program for heart failure (GWTG-HF) have improved their process of care. However, it is unclear if process of care and outcomes are better in the GWTG-HF hospitals compared with hospitals not enrolled. Methods and Results-We compared hospitals enrolled in GWTG-HF from 2006 to 2007 with other hospitals using data on 4 process of heart failure care measures, 5 noncardiac process measures, risk-adjusted 30-day mortality, and 30-day all-cause readmission after a heart failure hospitalization, as reported by the Center for Medicare and Medicaid Services (CMS). Among the 4460 hospitals reporting data to CMS, 215 (5%) were enrolled in GWTG-HF. Of the 4 CMS heart failure performance measures, GWTG-HF hospitals had significantly higher documentation of the left ventricular ejection fraction (93.4% versus 88.8%), use of angiotensin-converting enzyme inhibitor or angiotensin receptor antagonist (88.3% versus 86.6%), and discharge instructions (74.9% versus 70.5%) (PϽ0.005 for all). Smoking cessation counseling rates were similar (94.1% versus 94.0%; Pϭ0.51). There was no significant difference in compliance with noncardiac process of care. After heart failure discharge, all-cause readmission at 30 days was 24.5% and mortality at 30 days after admission was 11.1%. After adjustment for hospital characteristics, 30-day mortality rates were no different (Pϭ0.45). However, 30-day readmission was lower for GWTG hospitals (Ϫ0.33%; 95% CI, Ϫ0.53% to Ϫ0.12%; Pϭ0.002). Conclusions-Although there was evidence that hospitals enrolled in the GTWG-HF program demonstrated better processes of care than other hospitals, there were few clinically important differences in outcomes. Further identification of opportunities to improve outcomes, and inclusion of these metrics in GTWG-HF, may further support the value of GTWG-HF in improving care for patients with HF. (Circ Cardiovasc Qual Outcomes. 2012;5:37-43.)
I mproving the quality of care and clinical outcomes for patients hospitalized with cardiovascular disease and stroke is a challenging, but critically important, goal. The American Heart Association (AHA) developed the Get With The Guidelines (GWTG) program with the primary aim of improving care for patients with heart disease and stroke. 1, 2 Three GWTG program modules have been implemented and target hospital-based quality improvement for heart failure, stroke, and coronary artery disease. 3 Each module has a patient management tool that provides patient-specific guideline recommendations, allows for real-time data validation, and enables each institution to track its adherence to the guidelines individually and against national benchmarks. GWTG programs have demonstrated improved performance over time 4, 5 on process-of-care measures recommended by guidelines from the American College of Cardiology and the AHA. 6 -11 In addition to data collection, GWTG provides quality improvement tools to hospitals, including clinical decision support and dissemination of best practices, and regularly reports performance back to the participating hospitals.
Hospitals enrolled in GWTG have had better process of care for acute myocardial infarction than other hospitals when examined in a discrete time period. 12 However, it is unclear if GWTG for heart failure (GWTG-HF) hospitals are more likely to provide recommended care than nonparticipating hospitals. In addition, it is unclear if patient outcome is better at GWTG-HF hospitals.
To examine these issues, we compared hospitals enrolled in GWTG-HF with those not enrolled using publicly available process of care, 30-day rehospitalization, and 30-day mortality data from the Hospital Compare program of the Center for Medicare and Medicaid Services (CMS). By directly comparing hospitals within GWTG-HF with other hospitals for guideline adherence at a fixed period in time, we can avoid confounding by secular trends over time in quality of care.
Methods

Hospital Characteristics
We compared hospitals enrolled in GWTG-HF from 2006 to 2007 with other hospitals using Medicare patient data on process of care for heart failure, process of care for surgery and pneumonia, risk-adjusted 30-day mortality, and readmission for heart failure as reported by the CMS. Medicare beneficiaries are predominately Ͼ65 years, although some patients are eligible because of end-stage renal disease or disability.
Hospital characteristics were obtained from the American Hospital Association database and CMS, including bed size, profit status (government, private, or nonprofit), teaching status (yes or no), and US census region. The American Hospital Association survey 13 covers 98% of all hospitals, and missing items were rare (Ͻ5%).
WHAT IS KNOWN
• There is variation in process of care and outcome (30-day readmission and mortality) among US hospitals after a hospitalization for heart failure.
• The Centers for Medicare and Medicaid Services (CMS) publicly reports process of care and outcome of Medicare beneficiaries for individual US hospitals.
• The AHA has created a quality improvement program for hospitals called Get-With-The Guidelines.
WHAT THE STUDY ADDS
• Hospitals participating in Get With The Guidelines had better process of care, as defined by CMS, when compared with hospitals not participating in the program.
• Readmission rates may be slightly lower among hospitals participating in Get With The Guidelines compared with nonparticipating hospitals.
Process-of-Care Measures
We used hospital-specific process-of-care data from June 2006 to June 2007 reported by CMS. The performance measures are reported by hospitals based on specific criteria for eligibility that exclude patients with contraindications (Hospital Compare). 14
Heart Failure Measures
The heart failure measures included documentation of the following: (1) assessment of left ventricular function, (2) use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker for left ventricular systolic dysfunction (defined as an ejection fraction Ͻ40%), (3) provision of discharge instructions, and (4) counseling for smoking cessation. A composite heart failure measure was created by averaging all quality measures available per patient. Specifically, the composite score is defined as the total number of interventions performed divided by the total number of interventions for which the patient was eligible.
Noncardiac Measures
We obtained data for 5 noncardiac measures reported by CMS that address pneumonia and surgical care. The 4 pneumonia measures included documentation of the following: (1) pneumonia vaccination, (2) antibiotics within 6 hours of admission, (3) oxygen use, and (4) counseling for smoking cessation. A composite pneumonia measure was created by averaging all quality measures available per patient. The single surgical measure was preventive antibiotic 1 hour before incision.
Get With The Guidelines Program
Details of the GWTG Program have been described. 2, 3 In brief, the AHA launched the GWTG initiative with the goal of improving hospital care for coronary artery disease, stroke, and heart failure. GWTG uses a web-based patient management tool (Outcome Sciences, Inc; Cambridge, MA) to collect clinical data, provide decision support, and provide real-time online reports. Clinical data collected include patient demographics, medical history, symptoms on admission, in-hospital treatment and events, discharge treatment and counseling, and patient disposition. Participating institutions are instructed to submit consecutive eligible patients to the GWTG-HF database using case ascertainment techniques similar to the Joint Commission. 15 Institutions with large volumes (Ͼ75 cases per year) are allowed to submit a sample of cases through random selection on a quarterly basis.
All participating institutions were required to comply with local regulatory and privacy guidelines and, if required, to secure institutional review board approval. Because data were used primarily at the local site for quality improvement, sites were granted a waiver of informed consent under the common rule. Outcome Sciences, Inc (Cambridge), served as the registry coordinating center. The Duke Clinical Research Institute (Durham, NC) served as the data analysis center, and institutional review board approval was granted to analyze aggregate deidentified data for research purposes.
30-Day Readmission and Mortality Rates
We used risk-adjusted 30-day all-cause readmission and mortality data reported by CMS on their Hospital Compare Web site. 16 Risk-adjusted 30-day readmission and mortality are reported for patients discharged with a primary diagnosis of heart failure. The risk adjustment algorithms are based on demographics and prior and concurrent diagnoses, and the models' validation has been previously published. 17 
Statistical Analysis
Hospitals were excluded from an analysis of a particular performance measure if they reported to CMS on Ͻ25 patients for that measure. On average, 5% of GWTG and 14% of non-GWTG hospitals were excluded in analyses because of lack of CMS data. Excluded hospitals were smaller (lower average bed size) than included hospitals. GWTG and non-GWTG hospitals were compared using Pearson 2 tests for categorical variables and Wilcoxon rank-sum tests for continuous variables. Percentages were reported to describe categorical variables, and means with SDs and medians with 25 th and 75 th percentiles were reported for continuous variables. Hospitals were ranked based on the composite of the 4 HF processof-care measures, and then multivariable logistic regression analyses were performed to examine the association of GWTG participation with top quartile hospitals. The other covariates in the model included the potential hospital characteristic covariates: profit status, bed size, teaching status, and census region. The pneumonia and surgical composites served as control and were also included in the model to allow the comparison of GWTG-HF versus non-GWTG-HF centers, adjusted for hospitals' performance in noncardiac conditions. Similar multivariable regression analyses were performed to explore the relationship of GWTG participation and the risk-adjusted 30-day outcomes. Because CMS report estimates of hospitals' risk-adjusted outcome rates and variance of the estimates varied by hospitals, the weighted approach using the inverse of the estimate variance was used in the regression analyses. Although the readmission and mortality rates have already been adjusted by CMS for patient characteristics, 16, 17 differences in hospital characteristics might explain some differences in outcomes and, thus, the hospital characteristics were included in the model as adjustment. Missing covariate hospital data were Ͻ1%, and these patients were excluded in multivariable models.
All P values are 2 sided, with PϽ0.05 considered statistically significant. Analyses were performed using SAS software, version 9.2 (SAS Institute; Cary, NC).
Results
Hospital Characteristics
Facility characteristics for the 215 GWTG (5%) and 4245 (95%) other facilities are displayed in Table 1 . Hospitals enrolled in GWTG-HF were larger and more likely to be teaching institutions compared with hospitals not enrolled.
Process-of-Care Heart Failure Measures
Performance on the 4 main measures of inpatient heart failure care, as defined by the CMS, is shown in Table 2 and Figure   1 . Hospitals enrolled in the GWTG-HF had significantly more documentation of left ventricular ejection fraction (LVEF; absolute difference, 4.6%), use of angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers if the LVEF was Ͻ40% (absolute difference, 1.7%), and more patient education at discharge (absolute difference, 4.4%) when compared with other hospitals (PϽ0.05 for all). There was no difference in rates of smoking cessation counseling between GWTG-HF and other hospitals. However, a composite of all 4 measures was significantly higher for the GWTG-HF hospitals (absolute difference, 5.5%; PϽ0.0001).
Process-of-Care Surgical and Pneumonia Measures
Analyses were performed to determine if hospitals with better adherence to pneumonia and surgical care (markers of the institutions' overall, but noncardiac, quality of care) also performed well on the heart failure process measures. In contrast to the process of care findings for heart failure, GWTG-HF hospitals had no better compliance with process of care for pneumonia and surgical measures of quality than other hospitals (Table 3) .
Adjusted Differences in Process-of-Care Heart Failure Measures
After adjustment for hospital characteristics, hospitals enrolled in GWTG-HF were significantly more likely to be in the top 25% of hospitals ranked by the composite measure (odds ratio, 1.46; 95% CI, 1.06 -2.01). After additional adjustment for performance on pneumonia and surgical measures, the odds ratio for GWTG-HF hospitals being ranked in the top 25% on the heart failure composite remained significant (odds ratio, 1.73; 95% CI, 1.21-2.50). Table 4 displays the hospital characteristics associated with being in the top quartile for the heart failure composite process-of-care measure. Facilities were more likely to be in the top quartile if they were a GWTG-HF participant or a large (versus small) hospital and reported high levels of performance on the pneumonia and surgical composite process-of-care measures.
Hospital-Level Predictors of Process of Care
30-Day All-Cause Readmission
Readmission data were available for a wider time period (July 2005 and June 2008) than the other performance measures. There were 3923 hospitals with 30-day all-cause readmission data from CMS for at least 25 patients. Of these participants, 364 (9%) were enrolled in GWTG-HF. The 30-day all-cause readmission rate (risk adjusted for patient characteristics) was lower (24.2%) for GWTG-HF hospitals compared with non-GWTG-HF hospitals (24.6%; absolute difference, 0.4%; Pϭ0.0009; Table 5 ). When hospitals were ranked by 30-day readmission and separated into tertiles (Table 6) , GWTG-HF hospitals were more likely to be the lower readmission groups.
The impact of adjustment for hospital characteristics is shown in Figure 2 . After adjustment for hospital location, profit status, bed size, and teaching status, enrollment in GWTG-HF was associated with a small, but significant, decrease (Ϫ0.33%) in 30-day all-cause readmission (95% CI, Data are given as number (percentage) or meanϮSD. GWTG-HF indicates Get With The Guidelines-Heart Failure. *The bed size measure has 158 centers missing, 4% for both GWTG and non-GWTG groups.
†Teaching status data were missing for 206 hospitals (8% of GWTG-HF and 4% of non-GWTG-HF).
‡The region variable has 100 centers missing, 2% for both GWTG and non-GWTG groups.
Ϫ0.53% to Ϫ0.12%; Pϭ0.002). After additional adjustment for a composite of the 4 CMS process-of-care measures, GWTG-HF remained significantly associated with a decrease (Ϫ0.30%) in 30-day readmission (95% CI, Ϫ0.52% to Ϫ0.09%; Pϭ0.005).
30-Day Mortality
There were 3117 hospitals with mortality data for at least 25 patients. Of these, 188 (6%) were enrolled in GWTG-HF between July 2006 and June 2007. The 30-day mortality (risk adjusted for patient characteristics) was 11.1% for both GWTG-HF and non-GWTG-HF hospitals (Pϭ0.87). Similarly, when hospitals were ranked by 30-day mortality and separated into tertiles (Table 6) , there was no significant difference in the distribution of GWTG-HF and other hospitals. After adjustment for hospital location, profit status, bed size, and teaching status, enrollment in GWTG-HF was associated with no difference (0.07%) in 30-day mortality (95% CI, Ϫ0.12% to 0.26%; Pϭ0.45). These results were unchanged by additional adjustment using process-of-care measures (Figure 2) .
We examined the association between time in the GWTG-HF program and readmission rate (Figure 3 ). There were 73 facilities enrolled for Ͻ1 year, 116 enrolled for at least 1 and Ͻ2 years, 84 enrolled for at least 2 and Ͻ3 years, and 91 enrolled for Ն3 years. There was no significant association between time in the GWTG-HF program and the 30-day all-cause readmission rate. Hospitals may have participated in a precursor to the GWTG-HF program, and length of time in that program is not available.
Other Hospital-Level Predictors of Readmission and Mortality
Hospital characteristics significantly associated with decreased 30-day all-cause readmission rates included not-forprofit status (Ϫ0.29%) compared with government funding and West census region (Ϫ1.47%), Midwest census region (Ϫ0.80%), and South census region (Ϫ0.94%) compared with hospitals in the Northeast census region. An increase in performance by 10% on the heart failure composite processof-care measure was associated with a 0.1% decrease in the 30-day all-cause readmission rate (PϽ0.0001).
Hospital characteristics significantly associated with increased 30-day mortality included West census region (0.46% increase) and South census region (0.21% increase) compared with hospitals in the Northeast census region and fewer hospital beds (0.1% increase, for a decrease in 100 beds) compared with larger hospitals. The composite measure of heart failure process of care was not associated with adjusted 30-day mortality (Pϭ0.46). 
Discussion
Significant gaps, variations, and disparities in the use of guideline-recommended therapies for heart failure have been described. 7, 18 As a result, several hospital-based initiatives have been developed to improve quality of care and outcomes for patients hospitalized with heart failure, including GWTG-HF. Hospitals enrolled in the GWTG-HF program have demonstrated increased heart failure process of care over time at levels higher than historical controls. 12 In addition, those hospitals performing well on the GWTG-HF measures also performed well on similar measures when measured by CMS. 19 The current study shows that process of care, as defined by CMS performance measures, is higher in the GWTG-HF-participating hospitals than in other US hospitals. In addition, readmission rates, but not mortality, were lower in GWTG-HF hospitals. A 10% increase in the composite heart failure process-of-care measure was associated with a 0.1% decrease in all-cause readmission rates. Past studies 12 have shown that GWTG for coronary artery disease has better process of acute myocardial infarction care than non-GWTG hospitals. Our study demonstrates that this finding extends to the care of patients with heart failure. This may be expected given that the Get With the Guidelines program promotes improvement in hospital systems for cardiovascular disease that are not specific to a certain diagnosis. The GWTG program provides patient-specific guideline recommendations, frequent webinars aimed at improving quality of cardiovascular care, on-demand reports for each institution to track Data are based on 2946 hospitals (172 GWTG-HF and 2774 non-GWTG-HF) with both Center for Medicare and Medicaid Services data on all measures needed to create the composite and hospital characteristic data.
GWTG-HF indicates Get With The Guidelines-Heart Failure. GWTG indicates Get With The Guidelines; IQR, interquartile range. Get With The Guidelines-Heart Failure (GWTG-HF) and patient outcome. The impact of additional adjustment beyond case mix on the relationship between enrolling in GWTG-HF and outcome is shown for both 30-day rehospitalization and 30-day mortality. The differences in rate (GWTGϪother GWTG hospitals) with 95% CIs are shown. With risk adjustment alone, rehospitalization rates were significantly lower for GWTG hospitals. This difference persisted after adjustment for hospital characteristics and for process of care defined by the 4 performance measures for the Center for Medicare and Medicaid services. There was no obvious difference in mortality for hospitals enrolled and not enrolled in the GWTG-HF program.
performance, and a public award program that recognizes hospitals that meet 5 inpatient achievement measures. These include the 4 measures recognized by CMS and ␤-blockers at discharge if the LVEF is Ͻ40%. This overlap with the CMS measures may have helped focus the GWTG-HF hospitals to improve these processes of care. We found differences in 30-day readmission rates between GWTG and non-GWTG hospitals that were small but statistically significant. Although the reasons for the reduced readmission rates are unclear, they may be due, in part, to better process of care. 20, 21 We found that a higher composite process-of-care value was significantly associated with reduced readmission rates. However, better process of care, as defined by Medicare, explained only a small amount of the difference in readmission rates between GWTG-HF and other hospitals. Thus, GTWG-HF either worked in other ways to lower readmission rates or was a marker for other hospital factors associated with lower readmission rates. For example, there are other care processes that were targeted and improved in GWTG-HF that are associated with early postdischarge outcomes but are not included in CMS heart failure process measures (eg, ␤-blockers). 22 Better transition of care and postdischarge follow-up may also contribute to the lower rehospitalization rates observed. 23 Although the difference in readmission rates between GWTG-HF and other hospitals was Ͻ1% at 30 days, there are an estimated 240 000 readmissions at 30 days each year for heart failure (24% of 1 million admissions). If all hospitals could reach the 0.32% reduction seen after adjustment for patient and hospital characteristics, this would lead to Ͼ750 fewer readmissions (and potential savings of Ͼ4 million dollars) per year. Any hospital quality improvement activity used an undetermined amount of facility resources. At a minimum, each hospital had to collect data on each hospitalization.
The lack of a mortality effect is consistent with a prior study that found that GWTG-HF hospitals that were rewarded for Ն85% compliance with the 4 CMS heart failure measures did not have significantly better 30-day mortality after a heart failure admission (although post-myocardial infarction mortality was significantly reduced in GWTG hospitals). 19 Although the sample size of the current study was large, the differences in process of care were small and a small impact on mortality may be difficult to detect without a much larger cohort. The lack of mortality benefit may also be due to a lack of in-hospital therapies for heart failure, monitored by CMS, that have improved mortality. 24 Of the CMS performance measures for which hospitals are evaluated, only the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers at discharge for those with a depressed LVEF has improved survival in randomized trials. A stronger relationship between process of care and mortality may have been found if other life-prolonging therapies, such as ␤-blockers or aldosterone antagonist use in appropriate patients, were reported by CMS. 21 There are several potential limitations to our study. The improvements in performance measures may have been influenced by factors other than GWTG-HF participation. Our study could not determine if enrollment in Get-With-The Guidelines led to improved quality of care or was just a marker of hospitals that provide high quality of care. Hospitals enrolled in GWTG-HF may have been more interested in quality improvement because GWTG hospitals have had higher rates of accreditation than other hospitals in past studies. 19 To prove causality, a randomized trial of GWTG participation would be required. We attempted to control for preexisting hospital quality by controlling for pneumonia and surgical process of care. Although GWTG-HF hospitals had better heart failure process-ofcare and readmission rates than nonenrolled hospitals after adjustment for noncardiac process of care; this adjustment may have been inadequate to control for baseline hospital quality. Thus, it is possible that residual measured and unmeasured confounding may account for the observed differences. A long follow-up for outcome (for both mortality and admission) may be a better measure of the GWTG-HF program, and our readmission and mortality data were limited to 30 days. Although the inpatient GWTG program has both heart failure and stroke components, our analysis was limited to heart failure because CMS only reports data for heart failure.
We could not determine the difference in cost of care between those facilities participating and not participating in GWTG-HF. Thus, the financial impact of GWTG-HF participation is unclear.
The outcome for patients with Medicare may differ from non-Medicare patient outcomes, and we only had Medicare data available for the hospitals not enrolled in GWTG-HF. Hospital Compare process-of-care measure data are selfreported by hospitals, and facilities have an interest in reporting higher values for compliance with process of care. To address this, CMS audits randomly selected reports as part of a data quality assurance process. Finally, we could not determine what part of the GWTG program has the greatest impact on both process of care and readmission.
In summary, our study demonstrated that hospitals enrolled in the GWTG-HF program had better process of care and slightly better risk-adjusted 30-day readmission rates for heart failure than other hospitals publicly reporting data at the same time. This study suggests that quality improvement programs, such as GWTG, that improve use of recommended care strategies for heart failure may also reduce 30-day readmission rates. The quality of care provided to patients hospitalized with HF may be further enhanced by the GWTG-HF program features, including use of Web-based patient data submission and performance feedback, collaborative care models, and a focus on evidence-based care processes. Additional studies are needed to determine what hospital practices were most strongly associated with reduced readmission rates at the hospitals participating in GWTG-HF. In addition, more effective interventions are needed given the small improvement noted with the GWTG-HF program.
